Anúncio
Anúncio

ACHV

ACHV logo

Achieve Life Sciences, Inc.

5.20
USD
Patrocinado
+0.21
+4.25%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

5.21

0.00
+0.06%

Relatórios de Lucros ACHV

Rácio de surpresa positiva

ACHV separação 18 de 33 últimas estimativas.

55%

Próximo Relatório

Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.27
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-3.57%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-25.00%

Achieve Life Sciences, Inc. earnings per share and revenue

On 06 de nov. de 2025, ACHV reported earnings of -0.28 USD per share (EPS) for Q3 25, missing the estimate of -0.26 USD, resulting in a -6.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.27 USD, with revenue projected to reach -- USD, implying an diminuir of -3.57% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Achieve Life Sciences, Inc. reported EPS of -$0.28, missing estimates by -6.75%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.85%, changed from $4.93 before the earnings release to $4.74 the day after.
The next earning report is scheduled for 09 de mar. de 2026.
Based on 9 analistas, Achieve Life Sciences, Inc. is expected to report EPS of -$0.27 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio